相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Age-Specific IVF Outcomes in Infertile Women With Baseline FSH Levels 20 mIU/mL
Vitaly A. Kushnir et al.
REPRODUCTIVE SCIENCES (2018)
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial
Anders Nyboe Andersen et al.
FERTILITY AND STERILITY (2017)
Anti-Mullerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH
Helene Bry-Gauillard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy
Motohiro Kano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy
Kara N. Goldman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Ovarian reserve testing: a user's guide
Reshef Tal et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Effect of Exogenous Anti-Mullerian Hormone Treatment on Cryopreserved and Transplanted Mouse Ovaries
Hyun Sun Kong et al.
REPRODUCTIVE SCIENCES (2016)
Plasma Anti-Mullerian Hormone Concentrations and Risk of Breast Cancer among Premenopausal Women in the Nurses' Health Studies
A. Heather Eliassen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Steroid hormone pretreatments in assisted reproductive technology
Jean Nassar et al.
FERTILITY AND STERILITY (2016)
Improvements in IVF in women of advanced age
Norbert Gleicher et al.
JOURNAL OF ENDOCRINOLOGY (2016)
Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
Norbert Gleicher et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Intra-cellular mechanism of Anti-Mtillerian hormone (AMH) in regulation of follicular development
Emily Hayes et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency
Norbert Gleicher et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2016)
Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion
Irene Cimino et al.
NATURE COMMUNICATIONS (2016)
How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields
Norbert Gleicher et al.
ENDOCRINE (2016)
Anti-Mullerian Hormone Concentrations in Premenopausal Women and Breast Cancer Risk
Hazel B. Nichols et al.
CANCER PREVENTION RESEARCH (2015)
Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred
Norbert Gleicher et al.
FERTILITY AND STERILITY (2015)
Antimullerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis
Reshef Tal et al.
FERTILITY AND STERILITY (2015)
Optimizing outcomes from ovarian tissue cryopreservation and transplantation; activation versus preservation
Dror Meirow et al.
HUMAN REPRODUCTION (2015)
Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval
Yan-Guang Wu et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Genetics of androgen metabolism in women with infertility and hypoandrogenism
Aya Shohat-Tal et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome
Vitaly A. Kushnir et al.
JOURNAL OF OVARIAN RESEARCH (2015)
Short-Term PTEN Inhibition Improves In Vitro Activation of Primordial Follicles, Preserves Follicular Viability, and Restores AMH Levels in Cryopreserved Ovarian Tissue From Cancer Patients
Edurne Novella-Maestre et al.
PLOS ONE (2015)
Characterization of women with elevated antimullerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes
Reshef Tal et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2014)
Increased expression of antimullerian hormone and its receptor in endometriosis
Patrizia Carrarelli et al.
FERTILITY AND STERILITY (2014)
Increased Androgen, Anti-Mullerian Hmone, and Sporadic Anovulation in Healthy, Eumenorrheic Women: A Mild PCOS-Like Phenotype?
Lindsey A. Sjaarda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells
Pietro G. Signorile et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
The human Mullerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer Validation using the mAb 12G4
Nathalie Kersual et al.
MABS (2014)
Endocrine autoimmune diseases and female infertility
Aritro Sen et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol)
Yanping Kuang et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2014)
Anti Mullerian Hormone (AMH) level and expression in mural and cumulus cells in relation to age
Alon Kedem et al.
JOURNAL OF OVARIAN RESEARCH (2014)
Therapeutic Interventions into Early Stages of Follicle Maturation: A New Treatment Paradigm After Over 50 Years of Modern Infertility Therapy
Norbert Gleicher et al.
ENDOCRINOLOGY (2013)
Ovarian follicle culture: advances and challenges for human and nonhuman primates
Evelyn E. Telfer et al.
FERTILITY AND STERILITY (2013)
Anti-Mullerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments
Alon Kedem et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Hypoandrogenism in association with diminished functional ovarian reserve
Norbert Gleicher et al.
HUMAN REPRODUCTION (2013)
A lifelong model for the female reproductive cycle with an antimullerian hormone treatment to delay menopause
Alison Margolskee et al.
JOURNAL OF THEORETICAL BIOLOGY (2013)
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment
Kazuhiro Kawamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cyclophosphamide Triggers Follicle Activation and Burnout; AS101 Prevents Follicle Loss and Preserves Fertility
Lital Kalich-Philosoph et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Strategies to support human oocyte development in vitro
Evelyn E. Telfer et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2012)
Mullerian Inhibiting Substance Induces Apoptosis of Human Endometrial Stromal Cells in Endometriosis
Jeong Namkung et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Antimullerian hormone and polycystic ovary syndrome
Yi-Hui Lin et al.
FERTILITY AND STERILITY (2011)
A Validated Model of Serum Anti-Mullerian Hormone from Conception to Menopause
Thomas W. Kelsey et al.
PLOS ONE (2011)
Targeting the transforming growth factor-beta signaling pathway in human cancer
Nagathihalli S. Nagaraj et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Mullerian Inhibiting Substance/anti-Mullerian hormone: a potential therapeutic agent for human ovarian and other cancers
David T. MacLaughlin et al.
FUTURE ONCOLOGY (2010)
Is polycystic ovary syndrome an exception for reproductive aging?
Fahimeh Ramezani Tehrani et al.
HUMAN REPRODUCTION (2010)
Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance
Thanos D. Papakostas et al.
PROTEIN EXPRESSION AND PURIFICATION (2010)
Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
Athanasia Piouka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Evidence for a Mullerian-inhibiting substance autocrine/paracrine system in adult human endometrium
Jeff Wang et al.
FERTILITY AND STERILITY (2009)
The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome
Luciano G. Nardo et al.
HUMAN REPRODUCTION (2009)
Prospective Case-Control Study of Serum Mullerian Inhibiting Substance and Breast Cancer Risk
Joanne F. Dorgan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Microbial factories for recombinant pharmaceuticals
Neus Ferrer-Miralles et al.
MICROBIAL CELL FACTORIES (2009)
Localization of Mullerian inhibiting substance receptors in various human cancer cell lines
A. V. Rodina et al.
BIOCHEMISTRY-MOSCOW (2008)
Mullerian inhibiting substance type II receptor (MISIIR): A novel, tissue-specific target expressed by gynecologic cancers
Jamie N. Bakkum-Gamez et al.
GYNECOLOGIC ONCOLOGY (2008)
Mullerian-inhibiting substance induces gro-β expression in breast cancer cells through a nuclear factor-κB-dependent and Smad1-dependent mechanism
Vandana Gupta et al.
CANCER RESEARCH (2007)
Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-κB-dependent Smad-independent mechanism
Trinh T. Tran et al.
MOLECULAR ENDOCRINOLOGY (2006)
Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro
I. B. Carlsson et al.
HUMAN REPRODUCTION (2006)
Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo
R Pieretti-Vanmarcke et al.
CLINICAL CANCER RESEARCH (2006)
Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome
P Pigny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
A. La Marca et al.
CLINICAL ENDOCRINOLOGY (2006)
AMH and AMH receptor defects in persistent Mullerian duct syndrome
N Josso et al.
HUMAN REPRODUCTION UPDATE (2005)
Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance
EJ Renaud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility
AGMGJ Mulders et al.
HUMAN REPRODUCTION (2004)
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107
TU Barbie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The production of recombinant pharmaceutical proteins in plants
JKC Ma et al.
NATURE REVIEWS GENETICS (2003)
Mullerian inhibiting substance blocks the protein kinase Α-induced expression of cytochrome P450 17α-hydroxylase/C17-20 lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation
VM Laurich et al.
ENDOCRINOLOGY (2002)
Recent insights into organogenesis of the adrenal cortex
CE Keegan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Mullerian-inhibiting substance regulates NF-κB signaling in the prostate in vitro and in vivo
DL Segev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
New approaches for high-yield purification of Mullerian inhibiting substance improve its bioactivity
HK Lorenzo et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles
DB Seifer et al.
FERTILITY AND STERILITY (2002)
Mullerian inhibiting substance regulates NFκB signaling and growth of mammary epithelial cells in vivo
DL Segev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Anti-Mullerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors
R Rey et al.
HUMAN PATHOLOGY (2000)
Mullerian inhibiting substance inhibits breast cancer cell growth through an NFκB-mediated pathway
DL Segev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
